Cargando…
Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways
Oncolytic viruses (OVs) represent a new class of multi-modal immunotherapies for cancer, with OV-elicited antitumor immunity being key to their overall therapeutic efficacy. Currently, the clinical effectiveness of OV as monotherapy remains limited, and thus investigators have been exploring various...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554963/ https://www.ncbi.nlm.nih.gov/pubmed/36221123 http://dx.doi.org/10.1186/s12943-022-01664-z |